
Black Diamond Therapeutics BDTX
$ 1.72
2.35%
Country |
|
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
56.9 M |
Market Cap[1] |
$ 97.8 M |
EBITDA (LTM) |
$ 12.8 M |
P/E (LTM) |
5.435897 |
P/S (LTM) |
1.722291 |
EPS (LTM) |
0.39 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cyclacel Pharmaceuticals
CYCC
|
- | -5.98 % | $ 34.1 M | Nasdaq Capital Market | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
- | -4.36 % | $ 27 M | Nasdaq Capital Market | ||
|
Diffusion Pharmaceuticals
DFFN
|
- | 11.68 % | $ 8.97 M | Nasdaq Capital Market | ||
|
Eloxx Pharmaceuticals
ELOX
|
- | -5.68 % | $ 8.28 M | Nasdaq Global Market | ||
|
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | ||
|
Esperion Therapeutics
ESPR
|
- | - | $ 661 M | Nasdaq Global Market,SPB | ||
|
Evofem Biosciences
EVFM
|
- | 7.55 % | $ 38.1 M | Nasdaq Capital Market | ||
|
Eyenovia
EYEN
|
- | 49.81 % | $ 13.2 M | Nasdaq Capital Market | ||
|
FibroGen
FGEN
|
- | - | $ 889 M | Nasdaq Global Select Market,SPB | ||
|
Homology Medicines
FIXX
|
- | 0.77 % | $ 53.4 M | Nasdaq Global Select Market | ||
|
Amicus Therapeutics
FOLD
|
- | - | $ 4.47 B | Nasdaq Global Market,SPB | ||
|
Frequency Therapeutics
FREQ
|
- | - | $ 528 M | Nasdaq Global Select Market | ||
|
Galecto
GLTO
|
- | - | $ 762 M | Nasdaq Global Select Market | ||
|
GlycoMimetics
GLYC
|
- | 9357.83 % | $ 1.01 B | Nasdaq Global Market | ||
|
Graybug Vision
GRAY
|
- | -11.23 % | $ 9.65 M | Nasdaq Global Market | ||
|
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | ||
|
Happiness Biotech Group Limited
HAPP
|
- | 1.35 % | $ 17.8 M | Nasdaq Capital Market | ||
|
Hepion Pharmaceuticals
HEPA
|
- | -18.79 % | $ 39.3 K | Nasdaq Capital Market | ||
|
Hoth Therapeutics
HOTH
|
- | - | $ 18.8 M | Nasdaq Global Select Market | ||
|
IMARA
IMRA
|
- | 15.96 % | $ 663 M | Nasdaq Global Select Market | ||
|
KalVista Pharmaceuticals
KALV
|
- | - | $ 1.45 B | Nasdaq Global Select Market | ||
|
KemPharm
KMPH
|
- | -0.34 % | $ 200 M | Nasdaq Capital Market | ||
|
Kezar Life Sciences
KZR
|
- | - | $ 53.3 M | Nasdaq Global Select Market | ||
|
Lixte Biotechnology Holdings
LIXT
|
- | - | $ 63.4 M | Nasdaq Capital Market | ||
|
Magenta Therapeutics
MGTA
|
- | -7.74 % | $ 41.6 M | Nasdaq Global Select Market | ||
|
NovaBay Pharmaceuticals
NBY
|
- | - | $ 11.3 M | NYSE American | ||
|
NeuroBo Pharmaceuticals
NRBO
|
- | 0.43 % | $ 12 M | Nasdaq Global Select Market | ||
|
OncoCyte Corporation
OCX
|
- | 17.22 % | $ 355 K | NYSE American | ||
|
Onconova Therapeutics
ONTX
|
- | -0.47 % | $ 21 M | Nasdaq Capital Market | ||
|
Opthea Limited
OPT
|
- | - | $ 1.2 B | Nasdaq Global Select Market | ||
|
BiomX
PHGE
|
$ 1.85 | 14.2 % | $ 3.02 M | NYSE American | ||
|
Pieris Pharmaceuticals
PIRS
|
- | -15.58 % | $ 1.22 B | Nasdaq Capital Market | ||
|
Plus Therapeutics
PSTV
|
- | - | $ 301 M | Nasdaq Capital Market | ||
|
Pluristem Therapeutics
PSTI
|
- | -1.9 % | $ 33.3 M | Nasdaq Global Select Market | ||
|
Qualigen Therapeutics
QLGN
|
- | 5.59 % | $ 1.16 M | Nasdaq Global Select Market | ||
|
Qilian International Holding Group Limited
QLI
|
- | -6.08 % | $ 184 M | Nasdaq Global Select Market | ||
|
Cassava Sciences
SAVA
|
- | - | $ 110 M | Nasdaq Capital Market,SPB | ||
|
Selecta Biosciences
SELB
|
- | -8.69 % | $ 126 M | Nasdaq Global Market | ||
|
Sangamo Therapeutics
SGMO
|
- | - | $ 50.4 M | Nasdaq Global Select Market | ||
|
Salarius Pharmaceuticals
SLRX
|
- | - | $ 2.64 M | Nasdaq Global Select Market | ||
|
Sensei Biotherapeutics
SNSE
|
- | - | $ 17.5 M | Nasdaq Global Market | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
- | - | $ 826 K | Nasdaq Global Select Market | ||
|
Synthetic Biologics
SYN
|
- | 1.32 % | $ 16.2 M | NYSE American | ||
|
Synlogic
SYBX
|
- | - | $ 7.07 M | Nasdaq Global Market | ||
|
Virios Therapeutics, LLC
VIRI
|
- | 2710.01 % | $ 72.9 M | Nasdaq Capital Market | ||
|
Vallon Pharmaceuticals
VLON
|
- | -6.47 % | $ 5.76 M | Nasdaq Global Select Market | ||
|
Vaxart
VXRT
|
- | -25.06 % | $ 46.3 M | Nasdaq Capital Market,SPB | ||
|
XOMA Corporation
XOMA
|
- | - | $ 485 M | Nasdaq Global Select Market | ||
|
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market | ||
|
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.